Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001185185-25-001759
Filing Date
2025-11-17
Accepted
2025-11-14 18:19:13
Documents
15

Document Format Files

Seq Description Document Type Size
1 FORM S-3 igcs3111425.htm S-3 164538
2 EXHIBIT 5.1 igcex5-1.htm EX-5.1 7162
3 EXHIBIT 23.1 igcex23-1.htm EX-23.1 2739
4 FILING FEE TABLE igcex-fee.htm   iXBRL EX-FILING FEES 13409
5 GRAPHIC image_001.jpg GRAPHIC 5134
  Complete submission text file 0001185185-25-001759.txt   315893

Data Files

Seq Description Document Type Size
17 EXTRACTED XBRL INSTANCE DOCUMENT igcex-fee_htm.xml XML 4583
Mailing Address 10224 FALLS ROAD POTOMAC MD 20854
Business Address 10224 FALLS ROAD POTOMAC MD 20854 301-529-4996
IGC Pharma, Inc. (Filer) CIK: 0001326205 (see all company filings)

EIN.: 202760393 | State of Incorp.: MD | Fiscal Year End: 0331
Type: S-3 | Act: 33 | File No.: 333-291567 | Film No.: 251488632
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)